The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
1370245
WO Application Number:
SE02000401
Type:
European Patent Granted for NL
Status:
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Non-payment of the annual fee
Application number:
27018738
WO Publication Number:
WO02072074
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Sweden (SE)
Publications:
EP1370245;
Dates
Filing date:
06/03/2002
Grant date:
11/05/2005
EP Publication Date:
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
11/05/2005
EP B1 Publication Date:
11/05/2005
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
21/06/2005
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
05/03/2022
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
01/10/2009
Applicant/holder
From:
11/05/2005
Name:
AstraZeneca AB
Address:
151 85 Södertälje, Sweden (SE)
Domicile Holder
Name:
Dr. R. Jorritsma c.s.
From:
19/05/2005
Address:
N.V. Nederlandsch Octrooibureau, Postbus 29720, 2502 LS Den Haag, Netherlands (NL)